{"schema_version":"secwatch.filing_event.v1","accession":"0000059478-22-000143","form_type":"8-K","ticker":"LLY","cik":"0000059478","company_name":"ELI LILLY & Co","filed_at":"2022-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.323484+00:00","generated_at":"2026-06-25T23:08:56.212660+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Eli Lilly elects Dr. Mary Lynne Hedley to board effective May 15, 2022","bullets":["Dr. Mary Lynne Hedley elected to Lilly's Board of Directors, effective May 15, 2022.","She will serve on the Science & Technology Committee and the Ethics and Compliance Committee.","Hedley is a Senior Scientific Fellow at Broad Institute; previously co-founded TESARO (acquired by GSK) and served as President/COO.","Board determined she is independent under NYSE standards and company guidelines."],"urls":{"canonical":"https://secwatch.observer/filing/0000059478-22-000143","json":"https://secwatch.observer/filing/0000059478-22-000143.json","markdown":"https://secwatch.observer/filing/0000059478-22-000143.md","text":"https://secwatch.observer/filing/0000059478-22-000143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/0000059478-22-000143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/lly-20220502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:08:56.212660+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e90ab67905","claim":"Dr. Mary Lynne Hedley was elected as Director at ELI LILLY & Co.","evidence_excerpt":"On May 2, 2022, the Board of Directors (the “Board”) of Eli Lilly and Company (the “Company”) elected Dr. Mary Lynne Hedley as a new member of the class of 2025, effective May 15, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/0000059478-22-000143-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}